US BARDA radiation drug awards light up Avaxia, Apogee
This article was originally published in Scrip
Executive Summary
Biotechs Avaxia Biologics and Apogee Biotechnology this week won the first two contracts awarded by the US Biomedical Advanced Research and Development Authority (BARDA) for advanced development of drugs to treat gastrointestinal tract injuries associated with acute radiation syndrome.